{
    "nct_id": "NCT04092647",
    "official_title": "A Randomized Placebo-controlled Trial of Ashwagandha (Withania Somnifera) for Cognitive Dysfunction Associated With Cancer Chemotherapy.",
    "inclusion_criteria": "1. Age 18 years and older\n2. English speaking\n3. Currently undergoing chemotherapy or treatment with chemotherapy in the past year\n4. Self-reported memory loss, attention, visual-spatial functioning, reasoning, or information processing or cognitive changes in the first 2 cycles of chemotherapy and score < 63 on the FACT-Cog PCI\n5. Able to follow instructions for testing and comply with testing\n6. Able to swallow pills\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Undergoing treatment for any hormone dependent cancer\n2. Planned surgical treatment\n3. History of pre-existing dementia, untreated depression, psychiatric disorder, prior brain radiation or brain injury\n4. History of hypotension\n5. Active autoimmune disease\n6. Brain metastasis\n7. Taking any drugs daily that would alter cognition\n8. Concurrent use of benzodiazepenes or other sedatives\n9. Concurrent use of supplements that can cause sedation such as 5-HTP, calamus, California poppy, hops, Jamaican dogwood, kava, St.John's Wort, skullcap, valerian, yerba mansa\n10. Currently taking hypoglycemic medications\n11. History of substance abuse\n12. Current or recent diagnosis of stomach ulcer or gastritis",
    "miscellaneous_criteria": ""
}